Clinical Trial
Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients
Affiliations
- PMID: 2046273
Item in Clipboard
Clinical Trial
Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients
Kidney Int Suppl.
1991 Apr.
No abstract available
Similar articles
-
Choice of cholesterol-lowering drugs.Med Lett Drugs Ther. 1991 Jan 11;33(835):1-4. Med Lett Drugs Ther. 1991. PMID: 1984601 No abstract available.
-
Reducing cardiac deaths with hypolipidemic drugs.Postgrad Med. 1987 Nov 1;82(6):102-12. doi: 10.1080/00325481.1987.11700033. Postgrad Med. 1987. PMID: 3313343 Review. No abstract available.
-
Drug treatment of hyperlipidemia.Am Heart J. 1980 Oct;100(4):573-7. doi: 10.1016/0002-8703(80)90673-0. Am Heart J. 1980. PMID: 7415943 No abstract available.
-
Hypolipidemic drugs.Am Fam Physician. 1978 Feb;17(2):188-90. Am Fam Physician. 1978. PMID: 622945 No abstract available.
-
Contemporary recommendations for evaluating and treating hyperlipidemia.Clin Pharm. 1986 Feb;5(2):113-27. Clin Pharm. 1986. PMID: 3514084 Review.
Cited by
-
Should a 4-year-old girl with steroid-resistant nephrotic syndrome, hypercholesterolaemia and hypertriglyceridaemia be treated with lipid-lowering agents?Pediatr Nephrol. 1993 Dec;7(6):702. doi: 10.1007/BF01213326. Pediatr Nephrol. 1993. PMID: 8130086 No abstract available.
-
Hyperlipidemia in childhood nephrotic syndrome.Pediatr Nephrol. 1993 Oct;7(5):559-66. doi: 10.1007/BF00852550. Pediatr Nephrol. 1993. PMID: 8251323 Review.
-
Disturbances of lipid metabolism in children with chronic renal failure.Pediatr Nephrol. 1993 Dec;7(6):749-57. doi: 10.1007/BF01213345. Pediatr Nephrol. 1993. PMID: 8130098 Review.
-
Lipid-lowering agents for nephrotic syndrome.Cochrane Database Syst Rev. 2013 Dec 10;2013(12):CD005425. doi: 10.1002/14651858.CD005425.pub2. Cochrane Database Syst Rev. 2013. PMID: 24327265 Free PMC article.